BioSpace News Archive

Common warts, or cutaneous warts, are abnormal epithelial growth in the skin and mucous membrane. Common warts are known to be caused by the Human Papilloma Virus (HPV).

A wide range of assistive listening devices act as hearing aids to help individuals improve the communication of individuals with hearing loss.

The bone and joint health supplements market is rising steadily on the back of several favorable factors.

Targovax ASA, a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, announces its second quarter and first half year 2021 results.

Growing focus of major population from all across the world to improve their aesthetics is working as one of the key drivers for the development of the global alexandrite laser treatment market.

Cinclus Pharma Holding AB, a biopharmaceutical company focused on the development of a novel treatment for severe gastroesophageal reflux disease, announced that the first patient has been randomized in the Phase II dose ranging study for its lead candidate drug X842.

HistoIndex, a global leading artificial intelligence (AI) digital pathology provider, has announced an agreement with clinical-stage biotechnology company Sagimet Biosciences.

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), announced today positive data demonstrating the efficacy of multiple filovirus vaccine candidates in NHPs, including thermostabilized multivalent vaccines in a single vial platform presentation.

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the ROSA® Hip System for robotically-assisted direct anterior total hip replacement.

Cosmos Holdings, Inc., an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, and an extensive, established European Union distribution network, announced that the Company has entered into a debt exchange agreement with its senior lender to further reduce the Company’s debt.